Style | Citing Format |
---|---|
MLA | Biglari S, et al.. "Ataxia With Vitamin E Deficiency: Case Series, Vitamin E Therapy Response, Founder Effect, and in Silico Analysis." Clinical Genetics, vol. 107, no. 3, 2025, pp. 366-368. |
APA | Biglari S, Nikuei P, Mir A, Vahidnezhad H, Youssefian L, Moghaddam AS, Tabatabaiefar MA, Saeidian AH, Khorram E, Fard MAF, Farbood Z, Shahrooei M, Khorshid HRK, Esmaeilzadeh E (2025). Ataxia With Vitamin E Deficiency: Case Series, Vitamin E Therapy Response, Founder Effect, and in Silico Analysis. Clinical Genetics, 107(3), 366-368. |
Chicago | Biglari S, Nikuei P, Mir A, Vahidnezhad H, Youssefian L, Moghaddam AS, Tabatabaiefar MA, et al.. "Ataxia With Vitamin E Deficiency: Case Series, Vitamin E Therapy Response, Founder Effect, and in Silico Analysis." Clinical Genetics 107, no. 3 (2025): 366-368. |
Harvard | Biglari S et al. (2025) 'Ataxia With Vitamin E Deficiency: Case Series, Vitamin E Therapy Response, Founder Effect, and in Silico Analysis', Clinical Genetics, 107(3), pp. 366-368. |
Vancouver | Biglari S, Nikuei P, Mir A, Vahidnezhad H, Youssefian L, Moghaddam AS, et al.. Ataxia With Vitamin E Deficiency: Case Series, Vitamin E Therapy Response, Founder Effect, and in Silico Analysis. Clinical Genetics. 2025;107(3):366-368. |
BibTex | @article{ author = {Biglari S and Nikuei P and Mir A and Vahidnezhad H and Youssefian L and Moghaddam AS and Tabatabaiefar MA and Saeidian AH and Khorram E and Fard MAF and Farbood Z and Shahrooei M and Khorshid HRK and Esmaeilzadeh E}, title = {Ataxia With Vitamin E Deficiency: Case Series, Vitamin E Therapy Response, Founder Effect, and in Silico Analysis}, journal = {Clinical Genetics}, volume = {107}, number = {3}, pages = {366-368}, year = {2025} } |
RIS | TY - JOUR AU - Biglari S AU - Nikuei P AU - Mir A AU - Vahidnezhad H AU - Youssefian L AU - Moghaddam AS AU - Tabatabaiefar MA AU - Saeidian AH AU - Khorram E AU - Fard MAF AU - Farbood Z AU - Shahrooei M AU - Khorshid HRK AU - Esmaeilzadeh E TI - Ataxia With Vitamin E Deficiency: Case Series, Vitamin E Therapy Response, Founder Effect, and in Silico Analysis JO - Clinical Genetics VL - 107 IS - 3 SP - 366 EP - 368 PY - 2025 ER - |